Scientific work

Prof. Dr. Marıa Del Pılar Laguna Pes

491 publications. The source of the information is stated next to each publication.

Back to profile

  1. 179. K. Barwari, H. Wijkstra, O.M. van Delden, J.J. de la Rosette, M.P. Laguna Pes. Contrast-Enhanced Ultrasound for the Evaluation of the Cryolesion After Laparoscopic Renal Cryoablation: An Initial Report. J Endourol. 2013 Jan 15.

    Source: medipol.com.tr profile page

  2. 180. E.R. Cordeiro, K. Barwari, A. Anastasiadis, M. García, F. Branco, J.J. De la Rosette, M.P. Laguna Pes. Laparoscopic cryotherapy for small renal masses: Current State. Arch Esp Urol. 2013 Jan;66(1):41-53. English, Spanish.

    Source: medipol.com.tr profile page

  3. 181. M.N. Hew, P. Zondervan, S. Guven, J.J. De La Rosette, M.P. Laguna Pes. Prognostic models and factors for patients with renal cell carcinoma; a survey on their use amongst urologists. J Endourol. 2013 Feb 4.

    Source: medipol.com.tr profile page

  4. 182. M.P. Laguna Pes. Re: importance of cosmesis to patients undergoing renal surgery: a comparison of Laparoendoscopic Single-Site (LESS), laparoscopic and open surgery. J Urol. 2013 Feb;189(2):481.

    Source: medipol.com.tr profile page

  5. 183. M.P. Laguna Pes. Re: under-grading of <4 cm renal masses on renal biopsy. J Urol. 2013 Feb;189(2):480.

    Source: medipol.com.tr profile page

  6. 184. G. Verhoest, J. Patard, E. Oger, N. Rioux-Leclercq, B. Peyronnet, T. Bessède, M.P. Laguna Pes, K. Barwari, J. Rigaud, M. Roupret, G. Coffin, J. Bernhard, J. Long, A. Zisman, J. Berger, P. Paparel, C. Maurin, E. Lechevallier, R. Bertini, I. Ouzaid, L. Salomon, A. Bex, R. Farfara, B. Ljungberg, A.R. Rodriguez, K. Bensalah. Predictive factors of chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional study. Urol Oncol. 2013 Feb 18.

    Source: medipol.com.tr profile page

  7. 185. M.P. Laguna Pes. Re: validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients. J Urol. 2013 Mar;189(3):840-1.

    Source: medipol.com.tr profile page

  8. 186. M.P. Laguna Pes. Re: under-grading of <4 cm renal masses on renal biopsy. J Urol. 2013 Feb;189(2):480.

    Source: medipol.com.tr profile page

  9. 187. S. Houtzager, H. Wijkstra, J.J. de la Rosette, M.P. Laguna Pes. Evaluation of renal masses with contrast-enhanced ultrasound. Curr Urol Rep. 2013 Apr;14(2):116-23.

    Source: medipol.com.tr profile page

  10. 188. P. Gontero, S. Joniau, M. Oderda, M. Ruutu, H. Van Poppel H, M.P. Laguna Pes, J.J.M.C.H. de la Rosette, Z. Kirkali. Active surveillance for small renal tumors: have clinical concerns been addressed so far? Int J Urol. 2013 Apr;20(4):356-61.

    Source: medipol.com.tr profile page

  11. 189. J. Beyer, P. Albers, R. Altena, J. Aparicio, C. Bokemeyer, J. Busch, R. Cathomas, E. Cavallin-Stahl, N.W. Clarke, J. Claßen, G. Cohn-Cedermark, A. Dahl, G. Daugaard, U. de Giorgi, M. de Santis, M. de Wit, R. de Wit, K. Dieckmann, M. Fenner, K. Fizazi, A. Flechon, S.D. Fossa, J. Germá Lluch, J. Gietema, S. Gillessen, A. Giwercman, J. Hartmann, A. Heidenreich, M. Hentrich, F. Honecker, A. Horwich, R. Huddart, S. Kliesch, C. Kollmannsberger, S. Krege, M.P. Laguna Pes, L. Looijenga, A. Lorch, J. Lotz, F. Mayer, A. Necchi, N. Nicolai, J. Nuver, K. Oechsle, J. Oldenburg, J. Oosterhuis, T. Powles, E. Rajpert-De Meyts, O. Rick, G. Rosti, R. Salvioni, M. Schrader, S. Schweyer, F. Sedlmayer, A. Sohaib, R. Souchon, T. Tandstad, C. Winter, C. Wittekind. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol. 2013 Apr;24(4):878-88.

    Source: medipol.com.tr profile page

  12. 190. M.P. Laguna Pes. Re: systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. J Urol. 2013 May;189(5):1693-4.

    Source: medipol.com.tr profile page

  13. 191. M.P. Laguna Pes. Are we ready for molecular imaging-guided surgery? Eur Urol. 2014 May;65(5):965-6.

    Source: medipol.com.tr profile page

  14. 192. M.P. Laguna Pes. Re: limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases. J Urol. 2013 May;189(5):1692-3.

    Source: medipol.com.tr profile page

  15. 193. M.P. Laguna Pes. Re: Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. J Urol. 2013 Jun;189(6):2087-8.

    Source: medipol.com.tr profile page

  16. 194. M.P. Laguna Pes. Re: Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. J Urol. 2013 Jun;189(6):2088-9.

    Source: medipol.com.tr profile page

  17. 195. M.P. Laguna Pes. Re: regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada. J Urol. 2013 Jul;190(1):61.

    Source: medipol.com.tr profile page

  18. 196. J. Rassweiler, M.P. Laguna Pes, P. Chlosta, V. Pansadoro, F. Gaboardi, J. Stolzenburg, E. Barret, E. Liatiskos, L. Tunc, T. Frede, H. John, A. Bachmann, R. van Velthoven. ESUT Expert Group on Laparoscopy Proposes Uniform Terminology During Radical Prostatectomy: We Need to Speak the Same Language. Eur Urol. 2013 Jul;64(1):97-100.

    Source: medipol.com.tr profile page

  19. 197. M.N. Hew, P.J. Zondervan, S. Guven, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Prognostic models and factors for patients with renal-cell carcinoma: a survey on their use among urologists. J Endourol. 2013 Jun;27(6):790-9.

    Source: medipol.com.tr profile page

  20. 198. M.P. Laguna Pes. Re: Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. J Urol. 2013 Jun;189(6):2087-8.

    Source: medipol.com.tr profile page

  21. 199. M.P. Laguna Pes. Re: Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. J Urol. 2013 Jun;189(6):2088-9.

    Source: medipol.com.tr profile page

  22. 200. M.P. Laguna Pes. Re: positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. J Urol. 2013 Aug;190(2):493.

    Source: medipol.com.tr profile page

  23. 201. M.P. Laguna Pes. Re: Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. J Urol. 2013 Oct;190(4):1205-6.

    Source: medipol.com.tr profile page

  24. 202. K. Barwari, I.P. Kummerlin, F.J. ten Kate, F. Algaba, I. Trias, H. Wijkstra, J.J.M.C.H. De la Rosette, M.P. Laguna Pes. What is the added value of combined core biopsy and fine needle aspiration in the diagnostic process of renal tumours? World J Urol. 2013 Aug;31(4):823-7.

    Source: medipol.com.tr profile page

  25. 203. M.P. Laguna Pes. Re: Ipsilateral adrenalectomy at the time of radical nephrectomy impacts overall survival. J Urol. 2013 Oct;190(4):1205.

    Source: medipol.com.tr profile page

  26. 204. M.P. Laguna Pes. Re: Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols? J Urol. 2013 Nov;190(5):1711.

    Source: medipol.com.tr profile page

  27. 205. V.P. Alberts, R.C. Minnee, K.A. van Donselaar-van der Pant, F.J. Bemelman, P.J. Zondervan, M.P. Laguna Pes, Idu MM. Duplicated ureters and renal transplantation: a case-control study and review of the literature. Transplant Proc. 2013 Nov;45(9):3239-44.

    Source: medipol.com.tr profile page

  28. 206. M.P. Laguna Pes. Re: Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study. J Urol. 2013 Nov;190(5):1710.

    Source: medipol.com.tr profile page

  29. 207. M.P. Laguna Pes. Re: Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols? J Urol. 2013 Nov;190(5):1711.

    Source: medipol.com.tr profile page

  30. 207. M.P. Laguna Pes. Re: Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. J Urol. 2013 Dec;190(6):2017-8.

    Source: medipol.com.tr profile page

  31. 208. M.P. Laguna Pes. Re: A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update. J Urol. 2013 Dec;190(6):2017.

    Source: medipol.com.tr profile page

  32. 209. F.T. Furriel, M.P. Laguna Pes, Figueiredo AJ, Nunes PT, Rassweiler JJ. Training of European urology residents in laparoscopy: results of a pan-European survey. BJU Int. 2013 Dec;112(8):1223-8.

    Source: medipol.com.tr profile page

  33. 2014:

    Source: medipol.com.tr profile page

  34. 210. M.P. Laguna Pes. Re: carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up. J Urol. 2014 Jan;191(1):54-5.

    Source: medipol.com.tr profile page

  35. 211. M.P. Laguna Pes. Re: an investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. J Urol. 2014 Jan;191(1):55.

    Source: medipol.com.tr profile page

  36. 212. M.P. Laguna Pes. Re: parenchymal volume preservation and ischemia during partial nephrectomy: functional and volumetric analysis. J Urol. 2014 Feb;191(2):347.

    Source: medipol.com.tr profile page

  37. 213. M.P. Laguna Pes. Re: overall survival advantage with partial nephrectomy: a bias of observational data? J Urol. 2014 Feb;191(2):346-7.

    Source: medipol.com.tr profile page

  38. 214. P.G. Wagstaff, A. Ingels, P.J. Zondervan, J.J. de la Rosette, M.P. Laguna Pes. Thermal ablation in renal cell carcinoma management: a comprehensive review. Curr Opin Urol. 2014 Sep;24(5):474-82.

    Source: medipol.com.tr profile page

  39. 215. P.G. Wagstaff, P.J. Zondervan, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. The role of imaging in the active surveillance of small renal masses. Curr Urol Rep. 2014 Mar;15(3):386.

    Source: medipol.com.tr profile page

  40. 216. M.P. Laguna Pes. Re: everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. J Urol. 2014 Mar;191(3):626-7.

    Source: medipol.com.tr profile page

  41. 217. M.P. Laguna Pes. Re: Cumulative incidence of cancer after solid organ transplantation. J Urol. 2014 Apr;191(4):948-9.

    Source: medipol.com.tr profile page

  42. 218. M.P. Laguna Pes. Re: Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN project). J Urol. 2014 Apr;191(4):949.

    Source: medipol.com.tr profile page

  43. 219. M.P. Laguna Pes. Re: management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. J Urol. 2014 May;191(5):1262-3.

    Source: medipol.com.tr profile page

  44. 220. M.N. Hew, D. Opondo, E.R. Cordeiro, K.A. van Donselaar-van der Pant, F.J. Bemelman, M.M. Idu, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. The 1-year decline in estimated glomerular filtration rate (eGFR) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same. BJU Int. 2014 May;113(5b):E49-55.

    Source: medipol.com.tr profile page

  45. 222. M.P. Laguna Pes, F. Algaba, J. Cadeddu, R. Clayman, I. Gill, G. Gueglio, M. Hohenfellner, A. Joyce, J. Landman, B. Lee, H. van Poppel. Clinical Research Office of the Endourological Society Renal Mass Study. Current patterns of presentation and treatment of renal masses: a clinical research office of the endourological society prospective study. J Endourol. 2014 Jul;28(7):861-70.

    Source: medipol.com.tr profile page

  46. 223. M. Westendarp, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. [Diagnosis of upper urinary tract tumors. A pending challenge]. Arch Esp Urol. 2014 Jul;67(6):521-8. Spanish.

    Source: medipol.com.tr profile page

  47. 224. M.P. Laguna Pes. Re: Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. J Urol. 2014 Aug;192(2):369-70.

    Source: medipol.com.tr profile page

  48. 225. M.P. Laguna Pes. Re: Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC). J Urol. 2014 Aug;192(2):370.

    Source: medipol.com.tr profile page

  49. 226. M.P. Laguna Pes. Re: the predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study. J Urol. 2014 Sep;192(3):722.

    Source: medipol.com.tr profile page

  50. 227. M.P. Laguna Pes. Re: defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Urol. 2014 Sep;192(3):721-2.

    Source: medipol.com.tr profile page